Network-1 Technologies, Inc.

Financials

v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2026
Dec. 31, 2025
ASSETS   CURRENT ASSETS:    
Cash and cash equivalents $ 8,610,000 $ 13,402,000
Marketable securities, at fair value 25,979,000 23,467,000
Other current assets 195,000 237,000
  TOTAL CURRENT ASSETS 34,784,000 37,106,000
  OTHER ASSETS:    
Patents, net of accumulated amortization 1,810,000 1,479,000
Equity investments 2,786,000 1,734,000
Security deposit 13,000 13,000
        Total Other Assets 4,609,000 3,226,000
  TOTAL ASSETS 39,393,000 40,332,000
  LIABILITIES AND STOCKHOLDERS’ EQUITY: CURRENT LIABILITIES:    
Accounts payable 352,000 253,000
Accrued payroll 289,000
Other accrued expenses 758,000 228,000
Total Current Liabilities 1,110,000 770,000
  LONG TERM LIABILITIES:    
       Deferred tax liability 245,000
  TOTAL LIABILITIES 1,355,000 770,000
  COMMITMENTS AND CONTINGENCIES (Note H)  
  STOCKHOLDERS’ EQUITY    
Preferred stock, $0.01 par value, authorized 10,000,000 shares; none issued and outstanding at March 31, 2026 and December 31, 2025
Common stock, $0.01 par value; authorized 50,000,000 shares; 22,795,883  and 22,824,009 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 228,000 228,000
Additional paid-in capital 62,506,000 63,426,000
Accumulated deficit (24,696,000) (24,092,000)
TOTAL STOCKHOLDERS’ EQUITY 38,038,000 39,562,000
  TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 39,393,000 $ 40,332,000

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
REVENUE $ 150,000
OPERATING EXPENSES:    
Costs of revenue 42,000
Professional fees and related costs 775,000 121,000
General and administrative 596,000 602,000
Amortization of patents 44,000 30,000
TOTAL OPERATING EXPENSES 1,415,000 795,000
OPERATING LOSS (1,415,000) (645,000)
  OTHER INCOME (EXPENSE):    
Interest and dividend income, net 384,000 484,000
Gain on equity investment 1,052,000
Net realized and unrealized (loss) gain on marketable securities (287,000) 149,000
Total other income, net 1,149,000 633,000
INCOME (LOSS) BEFORE INCOME TAXES AND EQUITY IN NET LOSSES OF EQUITY METHOD INVESTEE (266,000) (12,000)
INCOME TAX PROVISION:    
Current
Deferred taxes, net 245,000 (111,000)
Total income taxes 245,000 (111,000)
(LOSS) INCOME BEFORE SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE (511,000) 99,000
SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE (462,000)
NET LOSS $ (511,000) $ (363,000)
Net loss per share:    
Basic $ (0.02) $ (0.02)
Diluted $ (0.02) $ (0.02)
Weighted average common shares outstanding:    
Basic 22,813,290 22,914,799
Diluted 22,813,290 22,914,799
Cash dividends declared per share $ 0.05 $ 0.05

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (511,000) $ (363,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of patents 44,000 30,000
Stock-based compensation 79,000 81,000
Gain on equity investment (1,052,000)
Loss allocated from equity method investment 462,000
Deferred tax expense (benefit) 245,000 (111,000)
Amortization of right of use asset 20,000
Unrealized loss (gain) on marketable net securities 361,000 (149,000)
Changes in operating assets and liabilities:    
Other current assets 42,000 38,000
Accounts payable 99,000 503,000
Operating lease obligations (17,000)
Accrued expenses 383,000 (335,000)
  NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES (310,000) 159,000
CASH FLOWS FROM INVESTING ACTIVITIES:    
Sales of marketable securities 3,429,000 4,199,000
Purchases of marketable securities (6,302,000) (3,500,000)
Acquisition of patents (375,000) (414,000)
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES (3,248,000) 285,000
  CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends paid (1,140,000) (1,144,000)
Value of shares delivered to fund payment of withholding taxes (9,000) (7,000)
Repurchases of common stock, inclusive of commissions (85,000) (150,000)
NET CASH USED IN FINANCING ACTIVITIES: (1,234,000) (1,301,000)
NET DECREASE IN CASH AND CASH EQUIVALENTS (4,792,000) (857,000)
CASH AND CASH EQUIVALENTS, beginning of period 13,402,000 13,145,000
CASH AND CASH EQUIVALENTS, end of period 8,610,000 12,288,000
Cash paid during the period for:    
Interest
Income taxes
NON-CASH FINANCING ACTIVITIES    
Accrued dividend rights on restricted stock units, net of forfeitures (142,000) 27,000
Right of use asset and lease liability

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL